The relevance of the current study is to increase the resistance of fungal biofilms to traditional disinfection methods. The aim of the study was to determine how effectively Er:YAG laser light inhibits single-species Candida biofilms. The study involved a systematic review of 57 scientific publications (2015–2024) selected according to specific criteria, followed by an assessment of quantitative and qualitative indicators of colony-forming unit reduction. The results show that under optimal parameters (power 1.5–3.9 W and duration 60–90 s), the Er:YAG laser can reduce the number of viable Candida albicans cells by an average of 70–90%, and when combined with sodium hypochlorite or chlorhexidine solutions, this figure can exceed 90%. Separate in vitro tests show that Candida glabrata and Candida tropicalis require higher power or longer exposure to achieve a similar effect, while the use of the Er:YAG laser on titanium and dental surfaces minimizes damage to the substrate and effectively removes the biofilm matrix. In addition, laser treatment accelerates tissue regeneration and helps reduce the number of cases of reinfection, which is confirmed by the positive dynamics in clinical practice. Data analysis using confocal microscopy and microbiological seeding indicates a significant disruption of the biofilm structure and increased permeability to antimycotics after laser exposure. Er:YAG laser disinfection method is promising in counteracting fungal biofilms, especially for surfaces with a high risk of microbial colonization. The practical value lies in the possibility of developing standard protocols for the clinical use of the laser, which will increase the effectiveness of treatment and prevention of Candidal lesions.

(1) Background: This study aimed to compare alveolar bone preservation and early healing outcomes following a comprehensive laser-assisted post-extraction protocol compared to conventional extraction alone. In addition, the potential influence of serum vitamin D levels on bone regeneration was assessed. (2) Methods: Thirty tooth extractions were performed and randomized into two groups: a test group (G1, n =15) and a control group (G2, n = 15). G1 received a laser-assisted protocol using Er:YAG and Nd:YAG lasers for granulation tissue removal, socket disinfection, clot stabilization, de-epithelialization, and photobiomodulation (PBM) with the Genova handpiece (LightWalker, Fotona, Slovenia). G2 underwent standard mechanical extractions and socket debridement without laser. (3) Results: Procedures in G1 were on average 8.7 min longer, but patients in this group reported significantly lower postoperative pain during the first three days (p < 0.05). A statistically significant difference in alveolar height was observed at the distal lingual site (25.4 mm vs. 21.7 mm; p = 0.046), with other sites showing a trend toward significance. Cumulative bone preservation, measured by Bone Loss Index (BLI4), was significantly better in the laser group. Notably, a positive correlation was found between serum vitamin D levels and bone preservation: each 1 ng/mL increase in vitamin D corresponded to a 0.18 mm gain in alveolar height (p = 0.021). (4) Conclusions: The comprehensive laser-assisted post-extraction protocol reduced postoperative pain and improved alveolar bone preservation, particularly at the lingual distal site. Serum vitamin D levels positively correlated with healing outcomes, suggesting a potential synergistic role of systemic and local regenerative factors.

Background: Snoring and mild to moderate obstructive sleep apnoea (OSA) are common sleep-related breathing disorders with increasing demand for minimally invasive treatment options. This study aimed to systematically evaluate the efficacy and safety of erbium:yttrium–aluminium–garnet (Er:YAG) laser therapy for these conditions. Methods: A systematic review and meta-analysis were conducted in line with PRISMA guidelines. Studies published between 2015 and 2025 were retrieved from major biomedical databases based on predefined inclusion criteria. Data were extracted on treatment outcomes, laser parameters, patient characteristics, and adverse effects. Results: Fifty-six studies were included. Er:YAG laser treatment, particularly in non-ablative SMOOTH and long-pulse modes, significantly reduced snoring intensity and improved subjective sleep quality. High patient satisfaction (65–85%) and a favourable safety profile were observed, with adverse effects generally mild and transient. Therapeutic effects typically lasted 12–24 months, though 25–40% of patients required maintenance sessions. Treatment success was associated with BMI, oropharyngeal anatomy, smoking status, and baseline apnoea-hypopnoea index scores (AHI 5–30 events/hour). Conclusions: Er:YAG laser therapy appears to be a safe and effective short- to medium-term treatment for selected patients with snoring or mild to moderate OSA. Optimising patient selection and treatment protocols may enhance long-term outcomes. Based on moderate-quality evidence for the immediate effects and safety profile, but low to very low quality evidence for long-term outcomes, erbium:yttrium–aluminium–garnet laser treatment appears to be a potentially effective and well-tolerated option for achieving short- to medium-term improvement in carefully selected patients with primary snoring or mild to moderate obstructive sleep apnoea. The practical significance of these findings lies in the refinement of candidate selection criteria, laser parameter settings, and the development of optimal protocols for long-term snoring control.

Background: Post-extraction alveolar bone resorption complicates implant planning and compromises functional and aesthetic outcomes. High-power lasers, including surgically applied Er:YAG and Nd:YAG lasers, as well as Nd:YAG-based photobiomodulation (PBM), have been proposed as adjunctive approaches to decontaminate extraction sockets, modulate inflammation, and stimulate osteogenesis, potentially limiting post-extraction ridge collapse. Methods: This systematic review and meta-analysis included prospective and retrospective clinical studies evaluating changes in alveolar ridge height, width, volume, or density following tooth extraction treated with Er:YAG, surgically applied Nd:YAG, or Nd:YAG-based PBM. Outcomes were assessed using cone-beam computed tomography (CBCT) or calibrated mechanical or optical measurement methods. Study selection followed PRISMA guidelines. Quantitative synthesis was performed using random-effects meta-analysis, and certainty of evidence was assessed using the GRADE approach. Results: All laser modalities demonstrated statistically and clinically significant preservation of alveolar bone compared with standard care. Er:YAG laser therapy resulted in a mean ridge preservation of 1.12 mm (95% CI: 0.9–1.4), while surgically applied Nd:YAG achieved a comparable effect of 1.15 mm (95% CI: 0.88–1.4). Nd:YAG-based PBM showed the most consistent effect, with a mean difference of 1.20 mm (95% CI: 1.0–1.4) and the lowest heterogeneity (I² = 22%). The largest effects were observed within the first month after extraction (mean difference 1.26 mm) and diminished with longer follow-up. CBCT-based assessments demonstrated the highest measurement precision, with an average effect of 1.32 mm. Overall certainty of evidence was rated as moderate due to risk of bias, incomplete methodological reporting, and possible publication bias. Conclusions: Er:YAG, Nd:YAG, and Nd:YAG-based PBM represent effective adjunctive approaches for alveolar ridge preservation following tooth extraction, particularly during the early healing phase. Their effects appear enhanced when combined with barrier membranes or osteoconductive grafting materials. CBCT should be preferred for outcome assessment in both clinical practice and research. These findings support the evidence-based integration of laser technologies into ridge preservation protocols in implant dentistry and oral surgery.